By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Imprimis Pharmaceuticals 

12264 El Camino Real
Suite 350
San Diego  California  92130-0001  U.S.A.
Phone: 858-704-4040 Fax: 858-345-1745


Key Statistics

Ownership: Public

Web Site: Imprimis
Symbol: immy

Company News
Imprimis (immy) Announces Fourth Quarter And Year-End 2016 Financial Results 3/22/2017 10:08:13 AM
Imprimis (immy) To Raise $3.1 Million In Registered Direct Offering 3/22/2017 7:30:17 AM
Imprimis (immy) Release: Peer-Reviewed Paper Demonstrates The Benefits Of Dropless Cataract Surgery 3/20/2017 11:12:06 AM
Imprimis (immy) Begins Dispensing from FDA-Registered 503B Outsourcing Facility 2/16/2017 6:35:08 AM
Imprimis (immy) And FocusScript Partner To Exclusively Offer The Correct Compound Program 12/21/2016 12:22:57 PM
Imprimis (immy) Announces Third Quarter 2016 Financial Results 11/15/2016 8:54:46 AM
Imprimis (immy) Signs Agreement With Specialty Pharmacy Division Of One Of The Nation's Largest Pharmacy Benefit Managers 11/11/2016 11:41:38 AM
Imprimis (immy) To Host Its Third Quarter 2016 Financial Report 11/3/2016 11:38:21 AM
Imprimis (immy) Registers Its New Jersey Facility With The FDA As An Outsourcing Facility 10/28/2016 8:30:39 AM
Imprimis (immy)' Dropless Therapy Shows Significant Advantages In A Large Peer-Reviewed Study 10/25/2016 8:39:34 AM